133 related articles for article (PubMed ID: 16387499)
21. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
Chang-Fong J; Tyacke RJ; Lau A; Westaway J; Hudson AL; Glennon RA
Bioorg Med Chem Lett; 2004 Feb; 14(4):1003-5. PubMed ID: 15013010
[TBL] [Abstract][Full Text] [Related]
22. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
May LT; Lin Y; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
[TBL] [Abstract][Full Text] [Related]
24. Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.
Ding K; Chen J; Ji M; Wu X; Varady J; Yang CY; Lu Y; Deschamps JR; Levant B; Wang S
J Med Chem; 2005 May; 48(9):3171-81. PubMed ID: 15857123
[TBL] [Abstract][Full Text] [Related]
25. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors.
Zlotos DP; Buller S; Holzgrabe U; Mohr K
Bioorg Med Chem; 2003 Jun; 11(12):2627-34. PubMed ID: 12757728
[TBL] [Abstract][Full Text] [Related]
26. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
[TBL] [Abstract][Full Text] [Related]
27. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
30. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
Lanzafame AA; Sexton PM; Christopoulos A
Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
[TBL] [Abstract][Full Text] [Related]
31. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
[TBL] [Abstract][Full Text] [Related]
32. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
Avlani V; May LT; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
[TBL] [Abstract][Full Text] [Related]
33. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.
Carter CR; Cao L; Kawai H; Smith PA; Dryden WF; Raftery MA; Dunn SM
Biochem Pharmacol; 2007 Feb; 73(3):417-26. PubMed ID: 17118342
[TBL] [Abstract][Full Text] [Related]
34. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
[TBL] [Abstract][Full Text] [Related]
35. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
[TBL] [Abstract][Full Text] [Related]
36. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
37. Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors.
Zlotos DP; Tränkle C; Holzgrabe U; Gündisch D; Jensen AA
J Nat Prod; 2014 Sep; 77(9):2006-13. PubMed ID: 25192059
[TBL] [Abstract][Full Text] [Related]
38. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
Tränkle C; Kostenis E; Burgmer U; Mohr K
J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
[TBL] [Abstract][Full Text] [Related]
39. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
Selent J; Brandt W; Pamperin D; Göber B
Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
[TBL] [Abstract][Full Text] [Related]
40. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
